Frederic Peyrade

Summary

Affiliation: Institut Paoli-Calmettes
Country: France

Publications

  1. ncbi Adapted CHOP plus rituximab in non-Hodgkin's lymphoma in patients over 80 years old
    Antoine Italiano
    Haematologica 90:1281-3. 2005
  2. doi Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial
    Frederic Peyrade
    Department of Onco Hematology, Centre régional de lutte contre le cancer de Nice, Nice, France
    Lancet Oncol 12:460-8. 2011
  3. doi Radioimmunotherapy in relapsed follicular lymphoma previously treated by autologous bone marrow transplant: a report of eight new cases and literature review
    Frederic Peyrade
    Centre Antoine Lacassagne, Nice, France
    Leuk Lymphoma 49:1762-8. 2008
  4. ncbi Quality of life after oral and oropharyngeal reconstruction with a radial forearm free flap: prospective study
    Alexandre Bozec
    Departement de Chirurgie, Institut Universitaire de la Face et Du Cou, Centre Antoine Lacassagne, 33 Avenue de Valombrose, Nice 06189, France
    J Otolaryngol Head Neck Surg 38:401-8. 2009
  5. doi Radical ablative surgery and radial forearm free flap (RFFF) reconstruction for patients with oral or oropharyngeal cancer: postoperative outcomes and oncologic and functional results
    Alexandre Bozec
    Departement de Chirurgie, Institut Universitaire de la Face et Du Cou, Centre Antoine Lacassagne, 33 Avenue de Valombrose, Nice, France
    Acta Otolaryngol 129:681-7. 2009
  6. doi Head and neck squamous cell carcinoma in patients aged > or = 80 years: patterns of care and survival
    Antoine Italiano
    Department of Medical Oncology, Antoine Lacassagne Center, Nice, France
    Cancer 113:3160-8. 2008
  7. ncbi Retreatment with 90Y-labelled ibritumomab tiuxetan in a patient with follicular lymphoma who had previously responded to treatment
    Frederic Peyrade
    Department of Medical Oncology, Antoine Lacassagne Centre, Nice, France
    Lancet Oncol 8:849-50. 2007
  8. doi Oral cavity squamous cell carcinoma in 260 patients aged 80years or more
    Cecile Ortholan
    Department of Radiotherapy, Centre Antoine Lacassagne, Nice, France
    Radiother Oncol 93:516-23. 2009
  9. doi Long-term quality of life and its predictive factors after oncologic surgery and microvascular reconstruction in patients with oral or oropharyngeal cancer
    Cédric S Pierre
    Department of Surgery, Institut Universitaire de la Face et Du Cou, 31 Avenue de Valombrose, 06103, Nice, France
    Eur Arch Otorhinolaryngol 271:801-7. 2014
  10. doi Ablative surgery and free flap reconstruction for elderly patients with oral or oropharyngeal cancer: oncologic and functional outcomes
    Eric Edi Martial Nao
    Department of Surgery, Institut Universitaire de la Face et Du Cou, Centre Antoine Lacassagne, Nice, France
    Acta Otolaryngol 131:1104-9. 2011

Collaborators

Detail Information

Publications26

  1. ncbi Adapted CHOP plus rituximab in non-Hodgkin's lymphoma in patients over 80 years old
    Antoine Italiano
    Haematologica 90:1281-3. 2005
    ..We show here that addition of rituximab to reduced-dose CHOP chemotherapy seems to be a good compromise between toxicity and efficacy, allowing clinicians to treat very elderly patients with a curative intent...
  2. doi Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial
    Frederic Peyrade
    Department of Onco Hematology, Centre régional de lutte contre le cancer de Nice, Nice, France
    Lancet Oncol 12:460-8. 2011
    ....
  3. doi Radioimmunotherapy in relapsed follicular lymphoma previously treated by autologous bone marrow transplant: a report of eight new cases and literature review
    Frederic Peyrade
    Centre Antoine Lacassagne, Nice, France
    Leuk Lymphoma 49:1762-8. 2008
    ..One other case of Grade 4 neutropenia, without a serious infectious syndrome, was observed. Standard-dose RIT seems feasible and potentially effective after ABMT in correctly selected patients with follicular lymphoma...
  4. ncbi Quality of life after oral and oropharyngeal reconstruction with a radial forearm free flap: prospective study
    Alexandre Bozec
    Departement de Chirurgie, Institut Universitaire de la Face et Du Cou, Centre Antoine Lacassagne, 33 Avenue de Valombrose, Nice 06189, France
    J Otolaryngol Head Neck Surg 38:401-8. 2009
    ..To evaluate quality of life (QOL) after radial forearm free flap (RFFF) reconstruction of the oral cavity and oropharynx in head and neck cancer patients...
  5. doi Radical ablative surgery and radial forearm free flap (RFFF) reconstruction for patients with oral or oropharyngeal cancer: postoperative outcomes and oncologic and functional results
    Alexandre Bozec
    Departement de Chirurgie, Institut Universitaire de la Face et Du Cou, Centre Antoine Lacassagne, 33 Avenue de Valombrose, Nice, France
    Acta Otolaryngol 129:681-7. 2009
    ..Radical ablative surgery and radial forearm free flap (RFFF) reconstruction provide promising oncologic and functional results in patients with oral or oropharyngeal cancer...
  6. doi Head and neck squamous cell carcinoma in patients aged > or = 80 years: patterns of care and survival
    Antoine Italiano
    Department of Medical Oncology, Antoine Lacassagne Center, Nice, France
    Cancer 113:3160-8. 2008
    ..Scarce data exist concerning the outcome of very elderly patients with head and neck squamous cell carcinoma (HNSCC)...
  7. ncbi Retreatment with 90Y-labelled ibritumomab tiuxetan in a patient with follicular lymphoma who had previously responded to treatment
    Frederic Peyrade
    Department of Medical Oncology, Antoine Lacassagne Centre, Nice, France
    Lancet Oncol 8:849-50. 2007
  8. doi Oral cavity squamous cell carcinoma in 260 patients aged 80years or more
    Cecile Ortholan
    Department of Radiotherapy, Centre Antoine Lacassagne, Nice, France
    Radiother Oncol 93:516-23. 2009
    ..We report the experience of two French cancer centers in the treatment of oral cavity squamous cell carcinoma (SCC) in patients aged 80 years...
  9. doi Long-term quality of life and its predictive factors after oncologic surgery and microvascular reconstruction in patients with oral or oropharyngeal cancer
    Cédric S Pierre
    Department of Surgery, Institut Universitaire de la Face et Du Cou, 31 Avenue de Valombrose, 06103, Nice, France
    Eur Arch Otorhinolaryngol 271:801-7. 2014
    ..In conclusion, T stage, tumor involvement of the tongue base, professional status and emotional and social functions were the main determinants of QoL in our study...
  10. doi Ablative surgery and free flap reconstruction for elderly patients with oral or oropharyngeal cancer: oncologic and functional outcomes
    Eric Edi Martial Nao
    Department of Surgery, Institut Universitaire de la Face et Du Cou, Centre Antoine Lacassagne, Nice, France
    Acta Otolaryngol 131:1104-9. 2011
    ..This was the first study to specifically demonstrate the validity of ablative surgery and free flap reconstruction for elderly patients with oral or oropharyngeal cancer in terms of oncologic and functional outcomes...
  11. doi Results of vocal rehabilitation using tracheoesophageal voice prosthesis after total laryngectomy and their predictive factors
    Alexandre Bozec
    Departement de Chirurgie, Institut Universitaire de la Face et Du Cou, Centre Antoine Lacassagne, 33 Avenue de Valombrose, 06189 Nice, France
    Eur Arch Otorhinolaryngol 267:751-8. 2010
    ..In conclusion the use of voice prosthesis showed a high success rate of vocal rehabilitation with an acceptable complication rate...
  12. doi Free-flap head and neck reconstruction and quality of life: a 2-year prospective study
    Alexandre Bozec
    Departement de Chirurgie, Institut Universitaire de la Face et Du Cou, Centre Antoine Lacassagne, Nice, France
    Laryngoscope 118:874-80. 2008
    ..This prospective study was designed to evaluate quality of life (QOL) after free-flap head and neck reconstruction...
  13. ncbi Molecular targeted therapies in the management of head and neck squamous cell carcinoma: recent developments and perspectives
    Alexandre Bozec
    Department of Surgery, Centre Antoine Lacassagne, 33 av de Valombrose, 06189, Nice, France
    Anticancer Agents Med Chem 13:389-402. 2013
    ..As these innovative molecules are beginning to be used in clinical practice, the identification of predictive markers for efficacy and toxicity is now a crucial issue...
  14. doi Impact of patient comorbidities on head and neck microvascular reconstruction. A report on 423 cases
    Clair Vandersteen
    Department of Surgery, Institut Universitaire de la Face et Du Cou, 31 Avenue de Valombrose, 06103 Nice, France
    Eur Arch Otorhinolaryngol 270:1741-6. 2013
    ..03) were significant predictors of medical complications. We concluded that the different subtypes of patient comorbidities were relevant predictors of complications in head and neck microvascular reconstruction...
  15. ncbi Significance of circulating tumor cell detection using the CellSearch system in patients with locally advanced head and neck squamous cell carcinoma
    Alexandre Bozec
    Department of Surgery, Institut Universitaire de la Face et Du Cou, 31 Avenue de Valombrose, 06103 Nice, France
    Eur Arch Otorhinolaryngol 270:2745-9. 2013
    ..12; Fisher's exact test). CTCs were identified in a relatively low proportion of patients with locally advanced HNSCC...
  16. doi [Pathogenesis and management of refractory malignant ascites]
    Esma Saada
    Centre Antoine Lacassagne, Departement d Oncologie Medicale, Nice, France
    Bull Cancer 98:679-87. 2011
    ..This review lists the current data reported on the pathophysiology of malignant ascites and describes the present and future options for refractory malignant ascites management...
  17. ncbi [Upper aerodigestive tract carcinoma: therapeutic management]
    Gilles Poissonnet
    Institut universitaire de la face et du cou de Nice et Centre Antoine Lacassagne, Nice
    Presse Med 36:1634-42. 2007
    ..Conservative treatment strategies must be favored. Treatment is essentially surgical and radiological. Prognosis for survival is poor. For all stages and sites together, 5-year survival remains between 30 and 40%...
  18. doi Systemic treatment and medical management of metastatic squamous cell carcinoma of the head and neck: review of the literature and proposal for management changes
    Frederic Peyrade
    Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France
    Oral Oncol 49:482-91. 2013
    ..Recently, new drugs have been incorporated in patient management, thus enabling an increase in OS. This review aims to define the comprehensive medical management of patients with relapsing head and neck carcinoma...
  19. ncbi Tumour response to paclitaxel in an adult with relapsed nephroblastoma
    Antoine Italiano
    Antoine Lacassagne Centre, Department of Medical Oncology, Nice, France
    Lancet Oncol 6:252-3. 2005
  20. doi Treatment decisions for elderly patients with haematological malignancies: a dilemma
    Frederic Peyrade
    Comprehensive Anticancer Centre, Medical Oncology, Nice, France
    Lancet Oncol 13:e344-52. 2012
    ..Additionally, we discuss how the implementation of geriatric tools, such as comprehensive geriatric assessment scores, in the clinical management of elderly patients might help to adapt treatment to meet individual patients' needs...
  21. doi Emerging molecular targeted therapies in the treatment of head and neck cancer
    Alexandre Bozec
    Centre Antoine Lacassagne, Department of Surgery, 33 av de Valombrose, 06189 Nice, France
    Expert Opin Emerg Drugs 14:299-310. 2009
    ..As these innovative molecules start to be used in clinical practice, the identification of predictive markers for efficacy and toxicity becomes a crucial issue...
  22. pmc Simalikalactone E (SkE), a new weapon in the armamentarium of drugs targeting cancers that exhibit constitutive activation of the ERK pathway
    Guillaume Robert
    INSERM U1065, C3M, Nice, France
    Oncotarget 3:1688-99. 2012
    ..In conclusion, we show that SkE, a very potent inhibitor of B-Raf-V600E, is highly effective against cancer cell lines that exhibit constitutive activation of the ERK1/2 pathway...
  23. ncbi French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC)
    Rene Jean Bensadoun
    Department of Radiation Oncology, Centre Antoine Lacassagne, Nice, France
    Int J Radiat Oncol Biol Phys 64:983-94. 2006
    ..Unresectable carcinomas of the oropharynx and hypopharynx still have a poor long-term prognosis. Following a previous phase II study, this phase III multicenter trial was conducted between November 1997 and March 2002...
  24. doi Diplopia as the first symptom of an aggressive metastatic rectal stromal tumor
    Jérôme Barrière
    Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France
    Onkologie 32:345-7. 2009
    ..Most common metastatic sites are the liver, the lungs, and the peritoneum. Bony metastases are uncommon and of unknown prognosis...
  25. doi Platinum-based chemotherapy plus cetuximab in head and neck cancer
    Jan B Vermorken
    Antwerp University Hospital, Department of Medical Oncology, Edegem, Belgium
    N Engl J Med 359:1116-27. 2008
    ..We investigated the efficacy of cetuximab plus platinum-based chemotherapy as first-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck...
  26. doi Cetuximab pharmacokinetics in end-stage kidney disease under hemodialysis
    Juliette Thariat
    J Clin Oncol 26:4223-5. 2008